Showing results (661-670 of 746) with videos related to

Sort By:
Pageof 75
The Lancet. Oncology|May 15, 2016
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 studyStephan Stilgenbauer, Barbara Eichhorst, Johannes Schetelig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2025
BRUIN CLL-313: Randomized Phase III Trial of Pirtobrutinib Versus Bendamustine Plus Rituximab in Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaWojciech Jurczak, Michal Kwiatek, Jaroslaw Czyz, et al.
The Lancet. Oncology|February 1, 2017
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trialAndrew D Zelenetz, Jacqueline C Barrientos, Jennifer R Brown, et al.
Nature|September 6, 2011
Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylationJang Hyun Choi, Alexander S Banks, Theodore M Kamenecka, et al.
Acta Haematologica|June 2, 2024
Safety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell MalignanciesLindsey E Roeker, Catherine C Coombs, Nirav N Shah, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Role of Cardiorespiratory Fitness and Mitochondrial Energetics in Reduced Walk Speed of Older Adults with Diabetes in the Study of Muscle, Mobility and Aging (SOMMA)Sofhia V Ramos, Giovanna Distefano, Li-Yung Lui, et al.
Hemasphere|September 25, 2025
Large B-cell lymphoma (LBCL): EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-upCatherine Thieblemont, Maria Gomes Da Silva, Sirpa Leppä, et al.
JCI Insight|February 10, 2025
Regulation of lung progenitor plasticity and repair by fatty acid oxidationQuetzalli D Angeles-Lopez, Jhonny Rodriguez-Lopez, Paula Agudelo Garcia, et al.
Pain|December 20, 2021
Antibody-induced pain-like behavior and bone erosion: links to subclinical inflammation, osteoclast activity, and acid-sensing ion channel 3-dependent sensitizationAlexandra Jurczak, Lauriane Delay, Julie Barbier, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 23, 2021
Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III StudyLarry W Kwak, Juan-Manuel Sancho, Seok-Goo Cho, et al.
Pageof 75